Dexcel PT Israel Ltd Strategic SWOT Analysis Review [Updated: 15022017] Prices from USD $125

09:34 EDT 14 Mar 2017 | BioPortfolio Reports

Dexcel PT Israel Ltd Strategic SWOT Analysis Review provides a comprehensive insight into the company's history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company's key employees, key competitors and major products and services.

This uptotheminute company report will help you to formulate strategies to drive your business by enabling you to understand your partners, customers and competitors better.


Business description A detailed description of the company's operations and business divisions.
Corporate strategy GlobalData's summarization of the company's business strategy.
SWOT analysis A detailed analysis of the company's strengths, weakness, opportunities and threats.
Company history Progression of key events associated with the company.
Major products and services A list of major products, services and brands of the company.
Key competitors A list of key competitors to the company.
Key employees A list of the key executives of the company.
Executive biographies A brief summary of the executives' employment history.
Key operational heads A list of personnel heading key departments/functions.
Important locations and subsidiaries A list of key locations and subsidiaries of the company, including contact details.
Key manufacturing facilities A list of key manufacturing facilities of the company.


Dexcel PT Israel Ltd Dexcel Pharma, a subsidiary of Dexcel PT Holdings Ltd, develops, manufactures and markets branded and generic pharmaceuticals. Its featured products include PerioChip chlorhexidine gluconate, a nonantibiotic adjunct treatment for scaling and root planing and adult periodontitis; Deximune, an immunosppressant; and omeprazole delayed released tablet. The company's other products include cetirizine, diclofenac, losartan, metoprolol tartrate, and nicorandil. Dexcel Pharma develops formulations using proprietary, patentprotected, drug delivery technologies. It offers products for allergy, analgesics, cardiovascular, dental, dermatology and pain relief, among others. The company sells its products in the US, the UK and Germany, among other countries. Dexcel Pharma is headquartered in Or Akiva, Haifa, Israel.

Reasons to Buy

Gain key insights into the company for academic or business research purposes. Key elements such as SWOT analysis and corporate strategy are incorporated in the profile to assist your academic or business research needs.
Identify potential customers and suppliers with this report's analysis of the company's business structure, operations, major products and services and business strategy.
Understand and respond to your competitors' business structure and strategies with GlobalData's detailed SWOT analysis. In this, the company's core strengths, weaknesses, opportunities and threats are analyzed, providing you with an up to date objective view of the company.
Examine potential investment and acquisition targets with this report's detailed insight into the company's strategic, business and operational performance.

Note: Some sections may be missing if data is unavailable for the company.

Original Article: Dexcel PT Israel Ltd Strategic SWOT Analysis Review [Updated: 15022017] Prices from USD $125


More From BioPortfolio on "Dexcel PT Israel Ltd Strategic SWOT Analysis Review [Updated: 15022017] Prices from USD $125"

Quick Search


Relevant Topics

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...

Drug Delivery
<!--LGfEGNT2Lhm-->Drug delivery is the method or process of administering a pharmaceutical compound to achieve a therapeutic effect in humans or animals.  <!--LGfEGNT2Lhm-->Drug delivery technologies are <!--LGfEGNT2Lhm-->patent pr...